NCT03638154View on ClinicalTrials.gov

Regenerative Potential of Cultured Gingival Fibroblast- Mesenchymal Stem Cells in Treatment of Periodontitis

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 15, 2016

Primary Completion Date

April 15, 2016

Study Completion Date

February 22, 2018

Conditions
Periodontal Intrabony Defect
Interventions
PROCEDURE

GF+GMSCs carried on β TCP

"surgical augmentation of GF+GMSCs carried on β TCP in intrabony periodontal defect and covered by collagen membrane(Bioresorb, Sybron, implant solutions GmbH Bremen, Germany) Cytoplast, RTM Collagen Cytoplast, Barrier Membranes, Osteogenics Biomedical, New Gersey, USA).~Ibuprofen"

PROCEDURE

β TCP bone substitute only

surgical augmentation by β TCP in intrabony periodontal defect(Bioresorb, Sybron, implant solutions GmbH Bremen, Germany) Ibuprofen

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03638154 - Regenerative Potential of Cultured Gingival Fibroblast- Mesenchymal Stem Cells in Treatment of Periodontitis | Biotech Hunter | Biotech Hunter